28th – 30th March 2017

London, UK

World CDx Europe: The go-to event for biomarker and drug development specialists

In this unprecedented competitive era for precision medicine and diagnostic developers, the 7th World CDx Europe Summit will once again unite large pharma, emerging biotech, diagnostic developers and technology experts who are dedicated to delivering the next generation of biomarker-driven precision medicines and high value diagnostics to robustly stratified patient populations.

Why visit World CDx Europe in 2017?

  • Learn best practice in validating emerging biomarkers, stratifying patient populations and defining appropriate responder cut offs to drive clinical success
  • Understand and decipher the cost/benefit analysis of embarking on a CDx strategy for therapies being developed in your portfolio
  • Identify the right diagnostic partners to work with and the right partnership model to define overarching personalised medicine/CDx strategy streamline approval and adoption of your drug

Click here to find out more

“The World CDx meetings have a great balance between academia, industry and pharma. They cover a broad range of technical, regulatory, and business issues related to the advancement of personalised medicine. ” - Richard Buller, VP, Clinical Development, Pfizer